AI assistant
Kalaris Therapeutics, Inc. — Director's Dealing 2021
Feb 19, 2021
34070_dirs_2021-02-18_61992288-2317-46e4-b93b-2e58eaa0e355.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Allovir, Inc. (ALVR)
CIK: 0001754068
Period of Report: 2021-02-16
Reporting Person: Vera Juan (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-16 | Common Stock | S | 9434 | $41.7939 | Disposed | 2457536 | Direct |
| 2021-02-16 | Common Stock | S | 966 | $42.5273 | Disposed | 2456570 | Direct |
| 2021-02-17 | Common Stock | S | 2000 | $38.7103 | Disposed | 2454570 | Direct |
| 2021-02-17 | Common Stock | S | 1400 | $40.0019 | Disposed | 2453170 | Direct |
| 2021-02-17 | Common Stock | S | 4060 | $41.2578 | Disposed | 2449110 | Direct |
Footnotes
F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.20 to $42.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.25 to $43.13. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.21 to $39.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.54 to $40.47. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.73 to $41.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.